MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • MassDevice Today
    • Cardiovascular
    • Clinical Trials
    • Legal News
    • Orthopedics
    • Regulatory/Compliance
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • More MedTech
    • Cosmetic/Aesthetic
    • Diabetes
    • Dialysis
    • Distribution
    • Imaging
    • Otolaryngology Ear, Nose & Throat
    • Pharma
    • Respiratory
    • Wound Care
  • Blog
  • DeviceTalks Podcasts
  • Resources
    • About MassDevice
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • White Papers
  • DeviceTalks

InVivo Therapeutics registers $8m offering

April 26, 2018 By Fink Densford Leave a Comment

InVivo Therapeutics (NSDQ:NVIV) today registered for an upcoming offering, looking to raise approximately $8 million, according to an SEC filing. In the offering, the Cambridge, Mass.-based company will look to offer shares of common stock and Series A warrants. The offering is slated to include a 45-day underwriter’s option for the purchase of additional shares, according […]

Filed Under: Business/Financial News, Funding Roundup, Wall Street Beat Tagged With: InVivo Therapeutics

InVivo plans 1-for-25 reverse stock split

April 9, 2018 By Fink Densford Leave a Comment

InVivo Therapeutics (NSDQ:NVIV) said today it is initiating a 1-for-25 reverse split of its stock, looking to put a single share in the hands of its shareholders for every 25 shares they previously owned. The move will reduce the company’s authorized shares from 100 million to just four million, the Cambridge, Mass.-based company said, and is […]

Filed Under: Business/Financial News, Wall Street Beat Tagged With: InVivo Therapeutics

InVivo wins FDA nod for new pivotal trial of its neuro-spinal scaffold

March 8, 2018 By Fink Densford Leave a Comment

InVivo Therapeutics (NSDQ:NVIV) said today it won FDA investigational device exemption for a new pivotal trial of its neuro-spinal scaffold after ending the previous Inspire study of the device in January. The Cambridge, Mass.-based company’s neuro-spinal scaffold is a novel, biodegradable device designed to be surgically implanted following acute spinal cord injuries to act as a physical […]

Filed Under: Clinical Trials, Food & Drug Administration (FDA), Neurological, Regulatory/Compliance, Spinal Tagged With: InVivo Therapeutics

Facing legal woes, PixarBio takes aim at InVivo

February 27, 2018 By Sarah Faulkner Leave a Comment

PixarBio (OTC:PXRB) faces its own legal problems: a possible lawsuit by the SEC, legal action by a disgruntled employee who is demanding unpaid wages and former landlords looking for $1.8 million in unpaid rent. But the 7-person biotech is also looking to launch some litigation of its own, according to a recent document it filed with the SEC […]

Filed Under: Legal News, Pain Management, Pharmaceuticals, Wall Street Beat Tagged With: InVivo Therapeutics, PixarBio

InVivo Therapeutics lifts Toselli to permanent prez, CEO | Personnel Moves February 6, 2018

February 6, 2018 By Fink Densford Leave a Comment

InVivo Therapeutics (NSDQ:NVIV) said yesterday it made Dr. Richard Toselli’s spot in the corner office permanent, lifting him from acting CEO to prez and CEO. Dr. Toselli will maintain his position on the company’s board and as its chief medical officer, the position he was given when he joined the company last July. Prior to joining InVivo, […]

Filed Under: Business/Financial News Tagged With: Alcon, Baxter, Boston Scientific, Faxitron, GE Healthcare, InVivo Therapeutics, johnsonandjohnson, Lima Corporate, Luxottica, Medizone, Medtronic, performancehealth, Respicardia, Robocath, Sanofi-Aventis, T2 Biosystems Inc.

InVivo Therapeutics inks $15m share purchase agreement

January 26, 2018 By Fink Densford Leave a Comment

InVivo Therapeutics (NSDQ:NVIV) said today it inked a stock purchase agreement with Lincoln Park Capital Fund to sell up to $15 million in shares over a two-year period. The new agreement comes with conditions and limitations, including giving the rights to InVivo to control the timing and amount of sales of stock and that the purchase […]

Filed Under: Business/Financial News Tagged With: InVivo Therapeutics

InVivo to end Inspire trial despite meeting primary endpoint, plans new study

January 3, 2018 By Fink Densford Leave a Comment

InVivo Therapeutics (NSDQ:NVIV) today released updated results from the Inspire study of its neuro-spinal scaffold but said that it would not be reopening enrollment, which it paused last July, and is instead looking to a new randomized controlled trial to supplement the results. The Cambridge, Mass.-based company said that 43.8% of the 16 living patients in the […]

Filed Under: Clinical Trials, Food & Drug Administration (FDA), Spinal Tagged With: InVivo Therapeutics

Zimmer Biomet lures Medtronic vet Hanson to CEO spot | Personnel Moves December 19, 2017

December 19, 2017 By Fink Densford Leave a Comment

Zimmer Biomet (NYSE:ZBH) said today it tapped former Medtronic (NYSE:MDT) exec VP Bryan Hanson as its new prez and CEO, replacing interim CEO Daniel Florin who will continue on as CFO and senior VP. A 20-year veteran of medical devices, Hanson operated most recently as group president of Fridley, Minn.-based Medtronic’s approximately $9 billion minimally invasive […]

Filed Under: Business/Financial News Tagged With: Bovie Medical Corp., Dentsply Sirona, Endologix, InVivo Therapeutics, Medtronic, milestonescientific, zimmerbiomet

InVivo pulls trigger on $2m warrant exchange

August 10, 2017 By Fink Densford Leave a Comment

InVivo Therapeutics (NSDQ:NVIV) said today it exchanged outstanding warrants, issued as part of a financing in 2014, for 2 million new shares of common stock. The exchange is worth approximately $2.4 million, given InVivo’s current share price of $1.20 as of 10:44 a.m. EDT. InVivo said it negotiated individual exchange agreements with warrant holders, and that […]

Filed Under: Business/Financial News, Wall Street Beat Tagged With: InVivo Therapeutics

InVivo adds 34th site to Inspire neuro-spinal scaffold trial

July 12, 2017 By Fink Densford Leave a Comment

InVivo Therapeutics (NSDQ:NVIV) said today it added Stanford Medicine as the 34th clinical in the Inspire study of its neuro-spinal scaffold. The Cambridge, Mass.-based company’s neuro-spinal scaffold is a novel, biodegradable device designed to be surgically implanted following acute spinal cord injuries to act as a physical substrate for nerve sprouting. Dr. Atman Desai has been […]

Filed Under: Clinical Trials, Spinal Tagged With: InVivo Therapeutics

InVivo adds 1st UK site to Inspire neuro-spinal scaffold study

July 11, 2017 By Fink Densford Leave a Comment

InVivo Therapeutics (NSDQ:NVIV) said today it added its 1st UK-based site to the Inspire study of its neuro-spinal scaffold at Middlesbrough’s James Cook University Hospital, bringing the total number of sites up to 33. The Cambridge, Mass.-based company’s neuro-spinal scaffold is designed to be surgically implanted following acute spinal cord injuries to act as a physical […]

Filed Under: Clinical Trials, Spinal Tagged With: InVivo Therapeutics

  • 1
  • 2
  • 3
  • …
  • 16
  • Next Page »
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us
Privacy
Add us on FacebookMassDevice Network
Follow us on Twitter@MassDevice
Connect with us on LinkedInLinkedIn
Connect with us on Google PlusGoogle+

Copyright © 2018 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy